Hypertension,Essential Clinical Trial
— FIHSTOfficial title:
The Föllinge Hypertension and Lifestyle Intervention; a Comparative Study of Methods for Blood Pressure Measurement and Survey of Living Habits
Verified date | December 2023 |
Source | Umeå University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Ambulatory blood pressure measurement is more demanding in terms of technical equipment and specially trained staff. If blood pressure measurement in a self-care room is on average equivalent to the ambulatory blood pressure daytime monitoring of hypertension in primary care could be simplified. We therefore want to examine patients monitored for hypertension (ICD 10) with three different methods: conventional blood pressure measurement in office, self-directed automated measurement and ambulatory blood pressure, starting in December 2020. We will also offer an interview covering cardiovascular risk factors, at time for enrollment and after 6 months. The study was approved to include 150 adult study patients (The swedish ethical review authority 2020-01375), men and women, where diagnosis and treatment of hypertension is relevant after a clinical evaluation.
Status | Active, not recruiting |
Enrollment | 117 |
Est. completion date | December 30, 2023 |
Est. primary completion date | December 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: - age 20 years or older - investigated or treated because of essential hypertension - registered at Föllinge Health Centre Exclusion Criteria: - patients in need of emergency care - advanced stages of disease or dementia - not able to perform self-directed blood pressure measurement - pregnancy - atrial fibrillation - arm circumference to small or wide for device - non consenting - re entry in same study |
Country | Name | City | State |
---|---|---|---|
Sweden | Gunnar Nilsson | Östersund | Region Jämtland Härjedalen |
Lead Sponsor | Collaborator |
---|---|
Umeå University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparative measurement of blood pressure | Systolic and diastolic pressure, in office, self directed and ambulatory | Hours 24 | |
Secondary | Assessment of modifiable cardiovascular risk factors | Modifiable risk factor scoring according to the questionnaire "Goda hälsoval gör skillnad" (www.hfsnatverket.se). Higher score indicating higher cardiovascular risk:
Tobacco, cigarettes per day: never smoker; previous =6 months; previous <6 months; daily smoker 1-9; 10-14; 15-20; >20. Alcohol, standard glasses per week: abstainer; <1; 1-4; 5-9; 10-14; =15 per week. (One standard glass equals 33 cm of beer or cider, 15 cl of wine or 4 cl of spirits.) Binge drinking, standard glasses; men =5, women =4: Never; <1/month; every month; every week; daily or almost daily. Minutes of physic activity for at least 10 minutes, within 1 week: No; <30; 30-60; 60-90; 90-150; 150-300; > 300 minutes (5 hours or more). Consumption of vegetables (fresh, boiled or frozen) servings per day: =2; 1; 2-6 servings per week; =1 servings per week. Consumption of fruit (fresh, boiled or frozen) servings per day: =2; 1day; 2-6 servings per week; =1 servings per week. |
Months 6 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05546931 -
Mobile Health Program for Rural Hypertension
|
N/A | |
Completed |
NCT05086549 -
An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria
|
||
Recruiting |
NCT05086523 -
Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03503773 -
The TARGET BP OFF-MED Trial
|
Phase 2 | |
Not yet recruiting |
NCT04082091 -
Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
|
||
Recruiting |
NCT06019598 -
Licorice and Home Blood Pressure, Additional Study
|
N/A | |
Completed |
NCT04495231 -
Sympathetic Activity and Cardiometabolic Complications
|
||
Completed |
NCT04119999 -
A Cardiosleep Research Program on Obstructive Sleep Apnea, Blood Pressure Control and Maladaptive Myocardial Remodeling
|
N/A | |
Recruiting |
NCT04505618 -
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
|
N/A | |
Recruiting |
NCT04863508 -
Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.
|
||
Completed |
NCT05185297 -
Recreational Futsal for Controlled Hypertension
|
N/A | |
Completed |
NCT03855605 -
Diagnosis of Hypertension by Home Blood Pressure Monitoring
|
||
Completed |
NCT03901183 -
Plant-based Nutrition for Patients With Cardiovascular Risk Factors
|
N/A | |
Recruiting |
NCT06348576 -
Phase III Study to Evaluate the Efficacy and Safety of AD-209
|
Phase 3 | |
Recruiting |
NCT03206814 -
Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
|
N/A | |
Recruiting |
NCT06343246 -
Functional Inspiratory Muscle Training in Patients Diagnosed With Hypertension
|
N/A | |
Completed |
NCT06359873 -
Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension
|
||
Recruiting |
NCT04565548 -
Hypertension Treatment Adherence Improving Trial
|
N/A | |
Recruiting |
NCT06205628 -
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
|
Phase 1 | |
Recruiting |
NCT04613193 -
Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis
|
N/A |